Lev Gerlovin, Brooke Bonet, and Inderpreet Kambo reviewed the use of several new and emerging digital health platforms to understand how digital health technologies can play a role in mitigating payer concerns about patient data management for personalized therapies. In this article published in Clinical Research News, the authors show that adoption of digital technologies can enhance the capture of real-world data related to patient outcomes and treatment compliance, and thereby facilitate broader use of value-based care models. The key to success is adopting the right technology at the right time.
Click here to read the article.
Gene therapy competitive dynamics: Winner takes all?
This article was originally published in Cell & Gene. It has also been published in Cell & Gene‘s sister publication, OutSourced Pharama. With many gene...